NCT07321171 Stepped-Care for Suicidal Youth and Children
| NCT ID | NCT07321171 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shira Barzilay |
| Condition | Suicidal Ideation and Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2024-05-07 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2024-05-07 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this RCT study is to test the efficacy of a stratified stepped-care (SSC) model in reducing suicidal thoughts and behaviors (STB) in children and adolescents. The main questions it aims to answer are: 1. Does the SSC model effectively reduce STB and mental health symptoms? 2. Can the SSC model improve access to treatment and be cost-effective? Researchers will compare the SSC model to Care as Usual (CAU). The SSC model includes low-intensity counseling delivered by non-specialists for mild STB and professional-delivered therapy for more severe cases. The CAU group will receive standard clinic treatment, which consists of a waitlist for brief therapy and follow-up. Participants will be recruited from a clinic at Schneider Children's Medical Center, randomly assigned to either the SSC group or the CAU group, and Complete assessments at the start of the study and at 1, 3, and 6 months.
Eligibility Criteria
Inclusion Criteria: * Participants must be between 6 and 18 years old, inclusive. * Participants currently exhibit various forms of STB, including suicidal thoughts, gestures, behaviors, or attempted suicide. Exclusion Criteria: * Acute medical conditions. * Current psychotic disorders. * Non-fluency in Hebrew (language of intervention and assessment). * Diagnosed intellectual disability. * Diagnosed neurodevelopmental disorders (other than those that commonly co-occur with STB and are deemed manageable by the study team). * Inability to provide informed consent (participant) or parental permission (parent/guardian).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07321171 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Suicidal Ideation and Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07321171 currently recruiting?
Yes, NCT07321171 is actively recruiting participants. Contact the research team at bshira@haifa.ac.il for enrollment information.
Where is the NCT07321171 trial being conducted?
This trial is being conducted at Petah Tikva, Israel.
Who is sponsoring the NCT07321171 clinical trial?
NCT07321171 is sponsored by Shira Barzilay. The trial plans to enroll 350 participants.